中华顶尖财经--信息搜索

信息搜索

信息关键字：药

共有3954条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198]

·展望2022：业内预测19款重磅新药获批2021-12-31 13:02:00

·利好传来医药细分赛道涨停潮资金抢筹名单出炉巨头价格战延续光伏产业降成本高回撤概念股一览2021-12-31 12:49:26

·中药政策点评：医保政策调整促进中医药行业发展2021-12-31 12:40:50

·万亿美元资本集团主席：美股牛市进入尾！看多优质中国医药公司…2021-12-31 12:40:32

·医药健康产业行业周报：中药政策相继落地产业迎来健康发展2021-12-31 12:36:57

·【机会挖掘】首批7个国家中医药综合改革示范区来了！机构称中医药行业迎来新机遇2021-12-31 12:32:37

·八大券商主题策略：中药股风起！板块上涨空间还有多大？产业链标的价值分析2021-12-31 11:25:52

·中药板块掀涨停潮佐力药业等十余股涨停2021-12-31 11:25:24

·新冠特效药再引“骚乱”迦南科技股价一个月涨165%引交易所关注2021-12-31 11:00:13

·行业重磅支持政策频发低估值中医药成资金避风港2021-12-31 10:34:42

·石药集团一款自主研发新药获准在国内开展临床试验2021-12-31 10:17:50

·中药板块继续走强2021-12-31 10:09:13

·RNA疗法第一股圣诺医药Sirnaomics登陆资本市场2021-12-31 9:31:53

·上榜“金智奖”！荣昌生物获中国医药生物产业优秀商业实践奖2021-12-31 9:23:38

·以岭药业与顺腾国际达成合作推动中医药产品与医疗服务在香港落地2021-12-31 8:45:46

·国泰君安：2022年零售药店板块景气度有望回升2021-12-31 8:05:26

·见证历史！国内首次连续30CM涨停！新冠药品大利好？公司深夜回应2021-12-31 7:57:14

·多只主题基金成立瞄准医药板块行情2021-12-31 7:03:17

·见证历史！国内首次，连续30CM涨停！新冠药品大利好？公司深夜回应…2021-12-31 6:42:24

·浙江医药子公司投资年产60万瓶重组人源化抗HER2单抗-AS269偶联制剂产业化项目总投资6.2亿2021-12-31 2:26:49

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198]